Form 4: Omnicell CEO Lipps' RSU Vesting & Tax Withholding

Omnicell CEO Randall Lipps reported the vesting of 79,494 performance-based restricted stock units and the withholding of 15,642 shares for tax obligations.

Summary

• Randall A. Lipps, Chairman, President, and CEO of Omnicell, Inc. (OMCL), reported transactions related to his beneficial ownership.
• 79,494 performance-based restricted stock units (RSUs) were acquired on March 15, 2026, following the Compensation Committee's determination on March 5, 2026, that 100% of the target performance criteria were met.
• These RSUs were originally granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index.
• 25% of the acquired RSUs vested on March 15, 2026, which was the one-year anniversary of the grant date.
• The remaining RSUs will vest in equal quarterly increments over a three-year period, specifically on May 15, August 15, November 15, and February 15.
• 15,642 shares of Common Stock were disposed of on March 15, 2026, at a price of $34.4 per share, to cover taxes due in connection with the vesting of restricted stock units.
• Following these transactions, Mr. Lipps directly beneficially owns 444,592.0741 shares of Common Stock.
• Additionally, Mr. Lipps indirectly beneficially owns 355,861 shares in trust with his wife and 8,051 shares in trust for his children.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as slightly positive due to the successful achievement of performance targets for the RSUs, indicating strong company performance relative to its peers. However, it is largely a routine compensation disclosure.

Positives

• The vesting of 79,494 performance-based restricted stock units indicates that Omnicell met 100% of its stock performance objectives compared to the S&P 1000 Healthcare Index, reflecting strong company performance over the measurement period.

Negatives

• The disposition of 15,642 shares to cover tax obligations reduces Mr. Lipps' direct beneficial ownership, which is a standard practice for RSU vesting but results in a decrease in his direct holdings.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that this Form 4 filing details an executive compensation event, specifically the vesting of performance-based restricted stock units and subsequent tax withholding. This is a routine disclosure for publicly traded companies and reflects the execution of a pre-existing compensation plan, rather than a direct indicator of broader industry trends or competitive shifts.

Stakeholder Impact

• Shareholders: The vesting of performance-based RSUs for the CEO aligns management incentives with shareholder value creation, as the performance criteria were met.
• Employees: This filing primarily concerns executive compensation and does not directly impact the broader employee base, though it reflects the company's overall performance.

Next Steps

• The remaining performance-based restricted stock units will vest in equal quarterly increments over a three-year period, specifically on each May 15, August 15, November 15, and February 15.

Key Dates

Keywords

Omnicell, OMCL, Randall Lipps, Form 4, Restricted Stock Units, RSU Vesting, Insider Transaction, Executive Compensation, Stock Performance